Articles tagged with: antiretroviral treatment (ART)

The evidence for U=U: why negligible risk is zero risk

published: August, 17, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Activism, Treatment Guidelines -including when to start, General Health, Current Affairs, Research, Health, International , Treatment, Media, Revolving Door, Guest Authors

From HIV i-Base, Simon Collins: "Purely theoretical risks are no longer a good enough level of evidence to sustain stigma and discrimination and certainly not criminalisation."

The evidence for U=U: why negligible risk is zero risk

Over the last year, hundreds of HIV organisations have joined a new campaign to endorse the statement that HIV transmission does not occur when viral load is undetectable on ART. And while the dramatic impact of ART on reducing HIV transmission has been known for a long time, it is new to say ART stops transmission completely. This change is especially important given that prejudice and discrimination against HIV positive people is still widespread. So while it is easy to simply answer “n

Restoring life again

published: July, 07, 2017 Written by // Kimutai Kemboi, Categories // Social Media, Activism, African, Caribbean and Black, Mental Health, Kimutai Kemboi, Health, International , Living with HIV, Media, Opinion Pieces

From Kenya, Kimutai Kemboi: "My appeal to people out there, who are stuck in a pool of denial and confusion, is to make a positive decision to start medication."

Restoring life again

"Is it true I am HIV positive?" I asked the lady in the white lab coat. "As per the test, it shows you are HIV positive." She replied.  I left the place immediately immediately. I had no interest in further discussion or counselling. I had drawn my own conclusions and I would decide my next course of action without influence from anybody. This was my life, though it wasn't life anymore, and I had a mandate to do what best suited me in my new condition. Suicide! Suicide! Suicide! Suicide!

Early doses, late doses, extra doses, missed doses: What's the risk? An HIV Doc Responds

published: May, 23, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Health, International , Treatment, Revolving Door, Guest Authors

From TheBody.com, renowned HIV physician Joel Gallant, M.D., M.P.H., fields questions about treatment adherence.

Early doses, late doses, extra doses, missed doses: What's the risk? An HIV Doc Responds

To read the complete article by Myles Helfand, visit The Body, here. Adherence imperfection is one of the more common concerns TheBody.com hears about from people taking once-daily HIV treatment regimens. They want to know: What's the penalty of a missed HIV medication dose? How much room is there for error if a person is off by an hour, or three hours, or an entire day? When it comes to meds, how human can a person get away with being? On his personal Tumblr, Joel Gallant, M.D., M.P.H.,

CTAC Talks! PrEP: A Game Changer for HIV Prevention in Canada?

published: May, 11, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Hep B and C, African, Caribbean and Black, Gay Men, Women, Opinion Pieces, Revolving Door, Guest Authors

CTAC Talks is an innovative web series highlighting treatment access issues and solutions for Canadians living with HIV and Viral Hepatitis.

CTAC Talks! PrEP: A Game Changer for HIV Prevention in Canada?

CTAC's expert guests, Joshua Edward, Dane Griffiths, Sipiwe Mapfumo and Fanta Ongoiba discuss the impact of Pre-Exposure Prophylaxis, or PrEP, which involves the use of antiretroviral medications by an HIV-negative person to prevent possible HIV transmission. For more information, visit the Canadian Treatment Access Council (CTAC), here.

Daily cannabis use has no negative Impact on HIV treatment

published: April, 04, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Alternative Therapies, Research, Health, International , Revolving Door, Guest Authors

From Culture Magazine, this report on the ACCESS study, which monitored cannabis use among HIV patients.

Daily cannabis use has no negative Impact on HIV treatment

This article previously appeared at Culture Magazine, here. Daily cannabis use has little or no impact on HIV clinical outcomes, according to new research. A study was published in The International Journal of Drug Policy which suggests that heavy cannabis use does not pose a threat to those who are on HIV medications. Data was derived from the ACCESS study, which monitored drug use among HIV patients. Between 2005 and 2015, 874 HIV positive patients in Vancouver, Canada were observed b

Q&A with Oghenowede Eyawo: research points to major shifts in mortality and causes of death among people living with HIV

published: March, 31, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , African, Caribbean and Black, Gay Men, Treatment Guidelines -including when to start, General Health, Women, Research, Health, Treatment, Revolving Door, Guest Authors

Two recent studies by the BC Centre for Excellence in HIV/AIDS (BC-CfE) point to what else has changed now that people living with HIV are expected to live much longer lives.

Q&A with Oghenowede Eyawo: research points to major shifts in mortality and causes of death among people living with HIV

People with HIV are now living longer, and are less likely to die from an AIDS-defining illness. What do we know about their health and quality of life today? People with HIV who are receiving combination antiretroviral drugs can now live full, long lives—increasingly comparable to those who are HIV-negative. Two recent studies by the BC Centre for Excellence in HIV/AIDS (BC-CfE) point to what else has changed now that people living with HIV are expected to live much longer lives. One study

Could cannabis treat HIV?

published: February, 15, 2017 Written by // Guest Authors - Revolving Door Categories // Alternative Therapies, Social Media, General Health, Research, Sexual Health, Health, International , Treatment, Revolving Door, Guest Authors

Jeannie Wraight and Mariel Selbovitz: More and more studies are surfacing that show just how important cannabis may be for the treatment of HIV.

Could cannabis treat HIV?

To read the entire article by Jeannie Wraight and Mariel Selbovitz, visit Plus, here. Support for medicinal marijuana has reached an all-time high in the United States. with over 70 percent of Americans in favor of the use of cannabis to lessen the effects of a large number of chronic medical conditions. People with HIV have long realized that cannabis can ease many HIV-related conditions, including nausea, loss of appetite, depression, weight loss, and neuropathic pain. In addition to trea

PrEP in Canada: What do we know about awareness, acceptability and use?

published: February, 14, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , African, Caribbean and Black, Gay Men, CATIE, Treatment Guidelines -including when to start, Research, Sexual Health, Health, Treatment, Media, CATIE - HIV and Hep C Info Resource

For CATIE, Camille Arkell reports on the current state of PrEP in Canada.

PrEP in Canada: What do we know about awareness, acceptability and use?

Une version française est disponible ici. Introduction A growing body of evidence tells us that oral pre-exposure prophylaxis (PrEP) is a highly effective strategy for reducing the risk of HIV transmission when used consistently and correctly. In February 2016, Health Canada approved the daily use of the drug Truvada as PrEP, in combination with safer sex practices, to reduce the risk of sexual HIV transmission for people at high risk of HIV infection. This approval was a necessary step

Good news from CATIE: what people need to know about Undetectable viral load and HIV sexual transmission

published: February, 08, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , Activism, CATIE, Current Affairs, Treatment Guidelines -including when to start, General Health, Mental Health, Research, Sexual Health, Health, Treatment, CATIE - HIV and Hep C Info Resource

CATIE says "people who are engaged in regular healthcare, are on treatment and have an ongoing undetectable viral load do not pass HIV to their sexual partners".

Good news from  CATIE: what people need to know about Undetectable viral load and HIV sexual transmission

This article previously appeared on the CATIE website here. Une version française est disponible ici. Studies have shown that HIV-positive people who are engaged in regular healthcare, are on treatment and have an ongoing undetectable viral load do not pass HIV to their sexual partners. This is great news! If I am HIV-positive how can I make this work for me? Talk to your doctor about treatment and an undetectable viral load as a prevention strategy. Before depending on this strategy,

People taking ART in the UK have an accurate understanding of their viral load

published: January, 26, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, General Health, Sexual Health, International , Treatment, Revolving Door, Guest Authors

Overall, 96% of people who told researchers their viral load was undetectable had a clinic-recorded viral load below 50 copies/ml, with 99% having a viral load below 1000 copies/ml. For AIDSmap.com, Michael Carter reports on new study.

People taking ART in the UK have an accurate understanding of their viral load

The vast majority of people taking antiretroviral therapy (ART) in the UK have an accurate knowledge of their current viral load (VL) level, investigators report in HIV Medicine. Overall, 96% of people who told researchers their viral load was undetectable had a clinic-recorded viral load below 50 copies/ml, with 99% having a viral load below 1000 copies/ml. “The accuracy of reporting an undetectable VL [viral load] by HIV-positive individuals on ART is directly relevant to their HIV

[12  >>